NanoCanada and the Nanomedicines Innovation Network are pleased to host a workshop that explores the new market potential in the nanomedicine ecosystem. Canada is a proven leader in nanomedicine and the current pandemic has shown the need for a quick response to global challenges. Bringing together key stakeholders in this ecosystem is vital for addressing the current barriers to scale-up.
Register here
Event Agenda (EDT)
| Time | Topic & Presenter |
| 13:30-13:35 | INTRODUCTORY REMARKS Marie D’Iorio, President, NanoCanada |
| 13:35- 14:00 | KEYNOTE TALK John Lewis, Founder & CEO, Entos Pharmaceuticals Ushering in a New Era of Genetic Medicines |
| 14:00 – 14:40 | PANEL DISCUSSION Building Canada’s Advanced Manufacturing Capacity in Nanomedicine MODERATOR: Nuzhat Tam-Zaman, Co-Founder & VP Consumer Health, SinoVeda a. Lloyd Jeffs, Senior Director of Clinical Manufacturing Solutions, Precision Nanosystems b. Lakshmi Krishnan, Acting VP Life Sciences, NRC c. Trina Racine, Associate Director – Vaccine Development, The Vaccine and Infectious Disease Organization (VIDO) |
| 14:40-15:10 | KEYNOTE TALK Tom Madden, CEO, Acuitas Therapeutics Supporting COVID-19 Vaccines and Perspective on Future Canadian Pandemic Preparedness |
| 15:10- 15:40 | FUNDING ANNOUNCEMENT Canada’s Nanomedicine Cluster a. Marie D’Iorio, President, NanoCanada b. Stéphane Gagné, CEO, Ovensa c. Ronda Gosselin, Industrial Technology Advisor, Atlantic & Nunavut, NRC-IRAP |
| 15:40-16:05 | KEYNOTE TALK Pieter Cullis, Scientific Director & CEO, The NanoMedicines Innovation Network The Importance of the Scientific Entrepreneur in the Translation of Academic Discoveries into the Commercial World |
| 16:05-16:10 | CONCLUDING REMARKS Diana Royce, Executive Director, The NanoMedicines Innovation Network |
